Dexamethasone acetate
Showing 26 - 50 of 3,517
Cataract Trial in Palo Alto, Charleston (Dexamethasone, Prednisolone Acetate Ophthalmic)
Recruiting
- Cataract
- Dexamethasone
- Prednisolone Acetate Ophthalmic
-
Palo Alto, California
- +1 more
Jan 3, 2022
Dry Eye Syndromes Trial in Sycamore (dexamethasone intraocular suspension, 9%, Prednisolone Acetate 1% Oph Susp)
Completed
- Dry Eye Syndromes
- dexamethasone intraocular suspension, 9%
- Prednisolone Acetate 1% Oph Susp
-
Sycamore, IllinoisHauser Ross Surgical Center
Jan 31, 2021
Corneal Edema, Corneal Defect, Corneal Transplant Trial in Los Angeles (Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate
Recruiting
- Corneal Edema
- +5 more
- Dextenza 0.4Mg Ophthalmic Insert
- Prednisolone Acetate 1% Oph Susp
-
Los Angeles, CaliforniaAdvanced Vision Care
Dec 23, 2020
Cataract Trial in Vineland (Dexamethasone, Prednisolone Acetate 1% Oph Susp)
Recruiting
- Cataract
- Dexamethasone
- Prednisolone Acetate 1% Oph Susp
-
Vineland, New JerseyEye Associates of Vineland
Mar 17, 2021
Postoperative Analgesia Trial in Assiut (Dexamethasone, Bupivacaine)
Completed
- Postoperative Analgesia
-
Assiut, Assiut Governorate, EgyptAssiut university hospitals
Apr 27, 2020
Cataract Trial in Laguna Hills, Garden City (Dexycu intracameral dexamethasone, Prednisolone Acetate)
Completed
- Cataract
- Dexycu intracameral dexamethasone
- Prednisolone Acetate
-
Laguna Hills, California
- +1 more
Dec 9, 2020
Ophthalmopathy , Lacrimal System Trial in Sohag (5 mg chloramphenicol, 1 mg dexamethasone sodium phosphate, 0.25 mg tetryzoline
Completed
- Ophthalmopathy , Lacrimal System
- 5 mg chloramphenicol, 1 mg dexamethasone sodium phosphate, 0.25 mg tetryzoline hydrochloride, 2 mg Hydroxypropyl Methyl Cellulose, 10 mg α-tocopherol acetate and 8 mg macrogol 400).
- sodium hyaluronate, polyethylene and propylene glycol based) three times daily for three months
-
Sohag, EgyptSohag University
Sep 3, 2021
Early-stage Breast Cancer, Pain Syndrome Trial in Newmarket, Ottawa (Dexamethasone tapering dose, Dexamethasone physician
Completed
- Early-stage Breast Cancer
- Pain Syndrome
- Dexamethasone tapering dose
- Dexamethasone physician choice
-
Newmarket, Ontario, Canada
- +1 more
Jan 6, 2020
Keloid, Hypertrophic Scar, Scars Trial (Betamethasone acetate + Betamethasone sodium phosphate, Dexamethasone sodium phosphate,
Unknown status
- Keloid
- +3 more
- Betamethasone acetate + Betamethasone sodium phosphate
- +3 more
- (no location specified)
Oct 18, 2020
Laparoscopic Cholecystectomy, Postoperative Nausea and Vomiting Trial in Banha, Tanta (normal Saline, Dexamethasone,
Not yet recruiting
- Laparoscopic Cholecystectomy
- Postoperative Nausea and Vomiting
- normal Saline
- +3 more
-
Banhā, Egypt
- +1 more
Aug 10, 2023
Ankle Disease, Ankle Injuries, Foot Injury Trial (0.9 % Sodium Chloride, 0.1mg/kg Dexamethasone, 0.05mg/kg Dexamethasone)
Not yet recruiting
- Ankle Disease
- +3 more
- 0.9 % Sodium Chloride
- +2 more
- (no location specified)
Oct 11, 2023
Wrist Disease, Hand Injuries, Wrist Injuries Trial (Placebo, 0.1mg/kg Dexamethasone, 0.05mg/kg Dexamethasone)
Not yet recruiting
- Wrist Disease
- +4 more
- Placebo
- +2 more
- (no location specified)
Oct 11, 2023
Irreversible Pulpitis Trial (Inferior alveolar nerve block with dexamethasone, Buccal infiltratation with dexamethasone,
Not yet recruiting
- Irreversible Pulpitis
- Inferior alveolar nerve block with dexamethasone
- +2 more
- (no location specified)
Jun 23, 2023
Wrist Disease, Hand Injuries and Disorders Trial (Sodium Chloride 0.9% Inj, 0,1mg/kg Dexamethasone, 0,2mg/kg Dexamethasone)
Not yet recruiting
- Wrist Disease
- Hand Injuries and Disorders
- Sodium Chloride 0.9% Inj
- +2 more
- (no location specified)
May 24, 2023
Caudal Block Trial (caudal block using dexamethasone, caudal block using methylprednisolone)
Not yet recruiting
- Caudal Block
- caudal block using dexamethasone
- caudal block using methylprednisolone
- (no location specified)
Jan 28, 2023
Ankle Disease, Foot Deformities, Foot Diseases Trial in Poznan (Sodium Chloride 0.9% Inj, 0,1mg/kg Dexamethasone, 0,2mg/kg
Not yet recruiting
- Ankle Disease
- +3 more
- Sodium Chloride 0.9% Inj
- +2 more
-
Poznań, Wielkopolska, Poland
- +1 more
May 24, 2023
Analgesia Trial in Damanhur (Dexmedetomidine Hydrochloride, Dexamethasone Phosphate)
Recruiting
- Analgesia
- Dexmedetomidine Hydrochloride
- Dexamethasone Phosphate
-
Damanhūr, El-Beheira, EgyptDamanhour Teaching Hospital
Mar 29, 2023
Acute Lymphoblastic Leukemia, Precursor B-Cell Lymphoblastic Leukemia, Precursor T-Cell Lymphoblastic Leukemia Trial in
Terminated
- Acute Lymphoblastic Leukemia
- +2 more
- Decitabine
- +6 more
-
Los Angeles, California
- +27 more
Oct 5, 2020
Immunoglobulin Light-chain Amyloidosis Trial (Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules
Not yet recruiting
- Immunoglobulin Light-chain Amyloidosis
- Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules combined with Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab
- Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab
- (no location specified)
Mar 18, 2023
Oral Lichen Planus, Mucous Membrane Pemphigoid, Pemphigus Vulgaris Trial in San Francisco (dexamethasone 0.5mg/5ml solution,
Completed
- Oral Lichen Planus
- +3 more
- dexamethasone 0.5mg/5ml solution
- dexamethasone 0.5mg/5ml solution in Mucolox™
-
San Francisco, CaliforniaSol Silverman Oral Medicine Clinic - UCSF
Jan 6, 2023
Multiple Myeloma Trial in Worldwide (ACY-1215 (Ricolinostat) in combination with pomalidomide and dexamethasone)
Active, not recruiting
- Multiple Myeloma
- ACY-1215 (Ricolinostat) in combination with pomalidomide and dexamethasone
-
Atlanta, Georgia
- +25 more
Aug 31, 2022
Postoperative Nausea and Vomiting, Postoperative Pain, Laparoscopic Cholecystectomy Trial (At-night Dexamethasone, At-induction
Not yet recruiting
- Postoperative Nausea and Vomiting
- +2 more
- At-night Dexamethasone
- At-induction Dexamethasone
- (no location specified)
Aug 17, 2023
Hepatocellular Carcinoma Trial (Aprepitant in combination with granisetron and dexamethasone, Granisetron and dexamethasone)
Not yet recruiting
- Hepatocellular Carcinoma
- Aprepitant in combination with granisetron and dexamethasone
- Granisetron and dexamethasone
- (no location specified)
Feb 2, 2023